Catheterization News and Research

RSS

Regional Medical Center Anniston to implement Wolters Kluwer Health's ProVation MD software

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Regional Medical Center Anniston has selected its ProVation® MD software for Cardiology procedure documentation and coding. The Anniston, AL-based hospital will use the software to document and code cases at its three cardiac catheterization labs.

27 Oct 2009

Transcatheter valve may eliminate repeat surgeries in children with heart defects; multicenter study shows good outcomes

Children born with certain heart defects have impaired blood flow from the right ventricle to the pulmonary artery leading to the lungs, requiring implanted devices (known as right-ventricular outflow tract conduits) to maintain the flow. However, these conduits fail over time, and children typically face multiple open-heart operations during their lives to reopen the passage.

27 Oct 2009

Experts discuss methods to prevent catheter-associated urinary tract infections

It's a statistic that almost every healthcare facility knows: 40 percent of all healthcare-acquired infections are urinary tract infections (UTI). Since catheters -- the most common source of these infections -- are used on over four million hospital patients a year, the chances of a patient getting a UTI are pretty high. In fact, the daily risk for patients acquiring a urinary infection is as high as seven percent when indwelling urethral catheters remain in their original position.

22 Oct 2009

Lake Health opens TriPoint Medical Center in Concord Township

Lake Health, formerly Lake Hospital System, today is celebrating the grand opening of its $155 million TriPoint Medical Center in Concord Township. A state-of-the-art digital hospital, TriPoint Medical Center is redefining the health care experience for patients, families and the community.

22 Oct 2009

AbbeyMoor Medical's The Spanner temporary prostatic stent insertion procedure receives Category I CPT code

AbbeyMoor Medical Inc. announced today they have been granted a Category I CPT code by the American Medical Association (AMA) for The Spanner(TM) temporary prostatic stent insertion procedure. This important action, effective in January 2010, upgrades The Spanner from a Category III emerging technology procedure code to a Category I procedure code for established procedures.

15 Oct 2009

NIH funds Urovalve to advance development of Surinate Bladder Management System

Urovalve, a medical device company focused on creating products for urinary flow and control, announced today that it has received $400,000 in new funding from the National Institutes of Health (NIH) to advance development of its Surinate Bladder Management System—designed to improve the quality of life of men who suffer from acute or chronic urinary retention, an inability to empty the bladder.

14 Oct 2009

Clarian Cardiovascular offers transradial cardiac catheterization

Clarian Cardiovascular has established the Midwest’s only Transradial Center of Excellence in an effort to offer patients a catheterization procedure that significantly reduces recovery time and improves patient outcomes – transradial cardiac catheterization.

9 Oct 2009

Summa Health System to implement ProVation MD software

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Summa Health System has selected ProVation® MD software for Cardiology procedure documentation and coding.

6 Oct 2009

Stem cell therapy aims to prevent permanent damage from heart attacks

All patients arriving at UCSF's Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.

1 Oct 2009

Cost-effective screening test for coronary artery disease

A simple, non-invasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death.

1 Oct 2009

Phase III PLATO study proves that ticagrelor is more effective than clopidogrel

New data from the phase III PLATO study showed that ticagrelor (BRILINTA((TM))) provided greater reduction of cardiovascular (CV) events (composite of CV death, heart attack and stroke) than clopidogrel (9.02% vs. 10.65%,>

25 Sep 2009

Z-Medica launches the QuikClot Interventional hemostatic bandage for use during catheterization procedures

Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced the availability of the QuikClot® Interventional™ hemostatic bandage, on display at booth #1338 at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

From Medica Corporation 24 Sep 2009

St. Jude Medical's cardiovascular healthcare portfolio to be presented at TCT meeting

St. Jude Medical, Inc. (NYSE:STJ) today announced it will display products and technologies from the company’s portfolio of solutions for cardiovascular healthcare professionals at the 21st annual Transcatheter Cardiovascular Therapeutics meeting in San Francisco. The featured products reflect the company’s continued commitment to developing comprehensive, high-performance solutions which advance the practice of interventional cardiology by improving efficiencies and giving physicians more control.

23 Sep 2009

New heart surgery method raises questions for reformers

A new method for performing cardiac catheterizations may be more comfortable, shows a lower chance of complications such as severe bleeding, and allows patients to be discharged more quickly, potentially saving money, the Washington Post reports.

23 Sep 2009

FemSoft from Rochester Medical included in the UK Drug Tariff

Rochester Medical Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R) Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a prescription product which is reimbursable.

22 Sep 2009

New wireless Fractional Flow Reserve system to evaluate blood flow blockages in the arteries

St. Jude Medical, Inc. (NYSE: STJ) today announced the first use of the PressureWire™ Aeris technology, an interventional tool which measures Fractional Flow Reserve (FFR) to evaluate the severity of blood flow blockages in the arteries. This first-to-market technology helps interventional cardiologists better determine the ideal treatment option for their patients during coronary interventions, such as stent procedures.

22 Sep 2009

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world’s most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.

22 Sep 2009

The Transcatheter Cardiovascular Therapeutics 2009 to feature PLCs' RenalGuard System

PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate its RenalGuard System(TM) at Transcatheter Cardiovascular Therapeutics (TCT) 2009, sponsored by the Cardiovascular Research Foundation, September 21 - 25, 2009, in San Francisco, California. More than 11,000 clinicians and professionals are expected to attend this event.

21 Sep 2009

AFib ablated using visually-guided laser balloon catheter

Physicians at The Mount Sinai Medical Center in New York became the first in the U.S. to ablate atrial fibrillation using a visually-guided laser balloon catheter.

21 Sep 2009

Black patients less likely to survive cardiac arrests in hospitals

Black patients have lower rates of successful resuscitation and are less likely to survive an in-hospital cardiac arrest compared to white patients, according to a study in the Sept. 16 issue of the Journal of the American Medical Association.

16 Sep 2009

Catheterization News and Research

Regional Medical Center Anniston to implement Wolters Kluwer Health's ProVation MD software

Transcatheter valve may eliminate repeat surgeries in children with heart defects; multicenter study shows good outcomes

Experts discuss methods to prevent catheter-associated urinary tract infections

Lake Health opens TriPoint Medical Center in Concord Township

AbbeyMoor Medical's The Spanner temporary prostatic stent insertion procedure receives Category I CPT code

NIH funds Urovalve to advance development of Surinate Bladder Management System

Clarian Cardiovascular offers transradial cardiac catheterization

Summa Health System to implement ProVation MD software

Stem cell therapy aims to prevent permanent damage from heart attacks

Cost-effective screening test for coronary artery disease

Phase III PLATO study proves that ticagrelor is more effective than clopidogrel

Z-Medica launches the QuikClot Interventional hemostatic bandage for use during catheterization procedures

St. Jude Medical's cardiovascular healthcare portfolio to be presented at TCT meeting

New heart surgery method raises questions for reformers

FemSoft from Rochester Medical included in the UK Drug Tariff

New wireless Fractional Flow Reserve system to evaluate blood flow blockages in the arteries

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

The Transcatheter Cardiovascular Therapeutics 2009 to feature PLCs' RenalGuard System

AFib ablated using visually-guided laser balloon catheter

Black patients less likely to survive cardiac arrests in hospitals

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News